Related by context. All words. (Click for frequent words.) 83 Rhucin R 78 Rhucin 72 Ruconest 69 alvimopan 68 Marketing Authorization Application 68 human C1 inhibitor 67 FIRAZYR 67 ecallantide 67 Firazyr 66 rhC1INH 66 acute HAE attacks 66 ezogabine 66 Soliris TM eculizumab 66 Icatibant 66 Loramyc R 65 ATPace TM 65 HepeX B 65 Loramyc ® 65 BENLYSTA 65 Centralized Procedure 65 MoxDuo IR 65 JOULFERON 65 SYCREST 65 Civacir 65 RHUCIN 65 ADVEXIN 65 Mycamine 65 Rhucin ® recombinant 64 Advagraf 64 oral methylnaltrexone 64 Decentralized Procedure 64 Zalbin 64 OMP designation 64 Plenaxis R 64 Somatuline R Autogel R 64 Marketing Authorization Applications 64 Alvesco R 64 MAA submission 64 Market Authorization Application 64 Esbriet pirfenidone 64 Q#IR 64 Glybera R 64 #D#C# 64 SNT MC# 64 Raptiva ® 64 Marketing Authorisation Application 64 QNEXA ® 64 BLA filing 64 GTC recombinant human 64 SUMAVEL 64 COMFORT II 63 ATryn ® 63 balsalazide tablet 63 Reclast Aclasta 63 Dacogen injection 63 PROMACTA 63 orphan medicinal product 63 SUMAVEL DosePro 63 Increlex ® 63 indiplon capsules 63 Angiox ® 63 FIRMAGON R 63 Increlex R 63 SEBIVO 63 Phenoptin 63 Prodarsan ® 63 Cellegesic 63 Fibrillex TM 63 Cimzia ® certolizumab pegol 63 orphan designation 63 BRILINTA 63 Stedivaze 63 methylnaltrexone 63 silodosin 63 CHMP recommendation 63 Pivotal Phase III 63 ATryn R 63 maribavir 63 Marketing Authorization Application MAA 63 RELISTOR ® 63 IMA# 63 Zebinix R 63 orBec 63 Certican 63 casopitant 63 dalbavancin 63 ponatinib 62 BLA submission 62 VPRIV 62 talactoferrin 62 Omigard 62 intravenous acetaminophen 62 MEPACT 62 Nebido 62 SILENOR TM 62 rilonacept 62 Ventavis 62 torezolid phosphate 62 KALBITOR ® 62 Marketing Authorization 62 Marketing Authorisation Application MAA 62 Raptiva R 62 Plenaxis TM 62 Orphan Status 62 Toctino R 62 acyclovir Lauriad R 62 velaglucerase alfa 62 highly purified pasteurized 62 Angiox 62 oxypurinol 62 UPLYSO 62 Exelbine 62 pegloticase 62 StaphVAX R 62 Cleviprex TM clevidipine 62 Neupro R 62 Evoltra TM 62 vernakalant hydrochloride 62 Acetavance TM 62 ARCOXIA 62 PREOS R 62 Adenuric R 62 Cinryze TM 62 FavId 62 PrevOnco ™ 62 Dyloject 62 registrational 62 pseudobulbar affect PBA 62 YONDELIS 62 hereditary angioedema 62 eltrombopag 62 Zingo TM 62 KALBITOR 62 IV APAP 62 Toctino ® 62 Gabapentin GR 62 eprodisate KIACTA TM 61 VIVITROL ® 61 ALGRX 61 Noxafil 61 Azilect ® 61 Trobalt 61 CHMP opinion 61 XAGRID 61 Corlux 61 Evoltra ® 61 Zelrix 61 BENLYSTA ® 61 Cinryze 61 NEBIDO 61 vosaroxin 61 albinterferon alfa 2b 61 MYLOTARG 61 Joulferon 61 ORENCIA ® 61 Kynapid 61 Firdapse 61 OvaRex ® MAb 61 ONTAK 61 Dalbavancin 61 Vimpat R 61 Cinryze ™ 61 Ambrisentan 61 ONSOLIS 61 RAPTIVA 61 JAK inhibitor 61 Targretin capsules 61 AZILECT R 61 granulated mesalamine 61 FACTIVE R gemifloxacin 61 RhuDex ® 61 HuMax CD4 61 Ketotransdel 61 Biologic License Application BLA 61 Xyrem ® 61 TEMODAL 61 Restanza 61 Exherin TM 61 Cladribine Tablets 61 Hereditary Angioedema 61 ketolide antibiotic 61 Anthim 61 Orphan Drug designations 61 bilastine 61 Orphan Drug status 61 Biologics License Application BLA 61 Soliris eculizumab 61 Prodarsan R 61 ZALBIN 61 RSD# oral 61 OLEPTRO TM 61 Phase IIIb clinical 61 canakinumab 61 Ceplene 61 REBETOL combination therapy 61 bazedoxifene 61 Glybera 61 Surfaxin LS 61 CONBRIZA 61 phase IIb clinical 61 clevidipine 61 ambrisentan 61 liprotamase 61 Ereska 61 XIAFLEX ™ 61 phase IIa clinical 61 Cimzia ® 61 FOLOTYN ® 61 Replagal 61 Preotact 61 Allovectin 7 61 C1 inhibitor 61 Zavesca r 61 Evoltra 61 prGCD 60 GRALISE 60 ranolazine 60 Fortigel 60 Locteron 60 DORIBAX 60 pitavastatin 60 MOZOBIL 60 BARACLUDE R 60 Emezine 60 Fodosine 60 ZADAXIN ® 60 Zerenex 60 Bicifadine 60 Cetrorelix 60 asenapine 60 metoprolol succinate 60 Orathecin 60 oral rivaroxaban 60 Onalta 60 zolpidem tartrate sublingual tablet 60 TYZEKA 60 IV acetaminophen 60 capsule formulation 60 ONGLYZA ™ 60 Tarceva TM 60 PrevOnco 60 ZEGERID Capsules 60 vilazodone 60 Ilaris 60 PROVIGIL 60 Xcytrin R 60 BEMA TM Fentanyl 60 AMITIZA R 60 ENTEREG ® 60 forodesine 60 Traficet EN 60 Amigal 60 IND submission 60 Besivance 60 investigational antiplatelet agent 60 GSK# [001] 60 Preotact R 60 hereditary angioedema HAE 60 acyclovir Lauriad ® 60 diabetic neuropathic pain 60 Aphthasol R 60 Dyloject TM 60 Mycograb 60 ruxolitinib 60 Shigamabs ® 60 Keppra ® levetiracetam 60 Orphan Drug Designation 60 Biologics License Application 60 taliglucerase alfa 60 European Medicines Evaluation 60 Virulizin R 60 Firazyr ® 60 FRDA 60 Fentanyl TAIFUN R 60 SinuNase TM 60 Eloxatin ® 60 refractory Hodgkin lymphoma 60 RSD# 60 rotigotine transdermal patch 60 ZOLINZA 60 SPRYCEL ® 60 Vimpat 60 Removab 60 nalbuphine ER 60 Restanza TM 60 Phase III clinical trials 60 Sebivo 60 Zenpep 60 Mutual Recognition Procedure 60 faropenem 60 Somatuline Depot 60 Orphan Medicinal Product 60 Kuvan 60 Jevtana 60 Aryplase 60 refractory gout 60 ORENCIA R 60 Zentase 60 EOquin 60 Catena ® 60 methylnaltrexone bromide 60 Anturol ® 60 Tekturna HCT 60 oxymorphone ER 60 sorafenib tablets 60 VIBATIV 60 Application BLA 60 REPLAGAL 60 THELIN 60 Intermezzo R 60 Rebif ® 60 teduglutide 60 Fast Track Status 60 Eltrombopag 60 guanfacine extended release 60 Polyphenon ® E 60 Orphan designation 60 Loramyc 60 OvaRex R 60 Generx TM 60 Linjeta TM 60 Keppra ® XR 60 Positive Opinion 60 mesylate tablets 59 Sycrest 59 T Pred 59 Spiegelmer ® 59 Telavancin 59 Abstral 59 ZEFTERA TM Zevtera TM 59 Tekamlo 59 BEMA Fentanyl 59 orBec R 59 Genasense R oblimersen 59 PLAVIX ® 59 Voraxaze ™ 59 Aclasta Reclast 59 NP2 Enkephalin 59 Aloxi R 59 Aclasta 59 Medicinal Products EMEA 59 MAGE A3 ASCI 59 DASISION 59 RIGScan CR 59 Archexin 59 QNEXA 59 Fast Track designation 59 crofelemer 59 Zenvia ™ 59 oral iron chelator 59 Rasagiline 59 Tracleer R 59 OPAXIO 59 Application MAA 59 drug ISA# 59 Stimuvax R 59 Oracea TM 59 Perforomist ™ Inhalation Solution 59 MGCD# [001] 59 ELAPRASE 59 TELCYTA 59 tafamidis 59 OMNARIS 59 FOLOTYN 59 Alzhemed TM 59 Ruconest ™ 59 alvespimycin 59 Proellex TM 59 Nivestim 59 ABILIFY R 59 octreotide acetate 59 BCX# 59 histamine dihydrochloride 59 ITAX 59 phase III isavuconazole 59 supplemental biologics 59 Orphan Drug Status 59 THALOMID 59 TORISEL 59 Tostrex 59 subcutaneous RELISTOR 59 EGRIFTA ™ 59 BYDUREON ™ 59 Trexima 59 FACTIVE tablets 59 Eligard ® 59 Bronchitol 59 FDA Approvable Letter 59 Santhera 59 HepaGam B 59 Plicera 59 FUSILEV ® 59 elotuzumab 59 KRYSTEXXA 59 Zolpimist 59 Marketing Authorisation 59 oral prodrug 59 injectable formulations 59 Fast Track designations 59 Onbrez Breezhaler 59 PDX pralatrexate 59 Rifaximin 59 Serdolect ® 59 Dificid 59 rThrombin 59 Golimumab 59 CIMZIA TM 59 human lactoferrin 59 hoFH 59 PANVAC VF 59 ONGLYZA 59 Silenor ® doxepin 59 motexafin gadolinium Injection 59 Retacrit 59 ELADUR 59 Fortical R 59 prucalopride 59 Arcalyst 59 telbivudine 59 Viviant 59 Cipralex ® 59 ceftobiprole 59 TELINTRA 59 Phase IIa clinical trials 59 Neupro ® 59 interferon beta 1b 59 AeroLEF TM 59 Amrubicin 59 HQK 59 Nabi HB Intravenous 59 confirmatory Phase 3 59 TRANSDUR Bupivacaine 59 sNDAs 59 TBC# 59 ALVESCO R 59 Gleevec Glivec 59 including eniluracil ADH 59 Qutenza 59 solifenacin succinate 59 severe gastroparesis 59 eprodisate Fibrillex TM 59 Soriatane 59 Hematide ™ 59 rufinamide 59 filgrastim 59 brivaracetam 59 Clolar 59 paliperidone ER 59 L MTP PE 59 receptor tyrosine kinase inhibitor 59 omacetaxine 59 levocetirizine 59 TRANSDUR Sufentanil 59 azficel T 59 IMVAMUNE R 59 trastuzumab DM1 T DM1 59 rALLy trial 59 amifampridine phosphate 59 Zyflo CR 59 ELIQUIS 59 Azedra 59 APF# 59 Movectro 59 LEUKINE 59 ACOMPLIA R 59 Oracea ® 59 JANUVIA 58 ADVANCE PD 58 Omigard TM 58 DAVANAT R 58 bifeprunox 58 ROTATEQ 58 Keppra XR 58 Taxotere ® 58 Biologics Licensing 58 rasagiline tablets 58 SUTENT ® 58 AERx iDMS 58 budesonide foam 58 Cimzia TM 58 lubiprostone 58 desvenlafaxine 58 Xyzal 58 Thelin TM 58 tanespimycin 58 tamibarotene 58 PLK1 SNALP 58 enoxaparin sodium 58 OFIRMEV 58 Keppra ® 58 Dabigatran etexilate 58 Exforge 58 Aurexis 58 Nexavar ® 58 Ophena TM 58 Ruconest TM 58 lumiliximab 58 TOCOSOL Paclitaxel 58 midstage studies 58 Romiplostim 58 adipiplon 58 Arranon 58 Voraxaze 58 Entereg R 58 Veronate 58 Hematide ™ peginesatide 58 Solazed 58 Extavia 58 ICA # 58 Velac 58 CRMD# 58 TYKERB 58 STEDESA 58 Anturol 58 Diamyd ® 58 LibiGel ® 58 sumatriptan DosePro 58 TRISENOX 58 Androxal ® 58 Sumavel DosePro 58 Tracleer r 58 Bendamustine 58 XIFAXAN R 58 severe hypercholesterolemia 58 Flutiform TM 58 Pirfenidone 58 POSIDUR TM 58 lomitapide 58 Ceplene TM 58 Yondelis ® 58 SILENOR 58 Orapred ODT 58 Urocidin 58 BYETTA ® 58 Frova ® 58 herpetic keratitis 58 oral FTY# 58 Entereg 58 Ceplene R 58 ZENPEP 58 Clolar ® 58 investigational hepatitis B 58 Riquent 58 nanofiltered plasma derived 58 budesonide MMX Phase III 58 CIMZIA ™ 58 CORLUX 58 Mepact 58 pancreatic enzyme replacement 58 Nexavar sorafenib 58 Hexvix 58 forodesine hydrochloride 58 Cimzia R 58 RAPAFLO 58 Feraheme ® 58 Brilique 58 Frova R 58 Qutenza TM 58 bioequivalency 58 MEZAVANT 58 Revolade 58 retigabine 58 omacetaxine mepesuccinate 58 NDA resubmission 58 CAPHOSOL 58 ABILIFY ® 58 Ramelteon 58 Fx #A 58 NUEDEXTA ™ 58 clobazam 58 NitroMist TM 58 CINOD 58 HuMax EGFr 58 bicifadine 58 BNC# 58 Jerini 58 huC# DM4 58 GALNS 58 candidate XP# 58 Anturol TM 58 REVLIMID R 58 Aviptadil 58 Vimpat ® lacosamide 58 AZILECT ® 58 ADAGIO study 58 Urokinase 58 ELACYT 58 Eraxis 58 dextromethorphan quinidine 58 Iluvien ® 58 OncoGel 58 chemotherapy induced neutropenia 58 Promacta 58 Rescula 58 Tekturna Rasilez 58 Clonicel 58 Actimmune ® 58 Relivar 58 IRESSA 58 NUVIGIL 58 Focetria 58 opioid induced bowel dysfunction 58 sBLA 58 Treximet 58 Orphan Designation 58 Teysuno 58 alitretinoin 58 HEPLISAV TM 58 Phase IIa trial 58 EDEMA3 58 nonclinical studies 58 Levetiracetam 58 cangrelor 58 IND CTA 58 peginesatide 58 WILEX 58 OMAPRO ™ 58 MGN# 58 AERIUS 58 dose cohort 58 PRT# 58 Resolor 58 Dextofisopam 58 NerPharMa 58 Torisel 58 pralatrexate 58 COLAZAL R 58 EndoTAG TM -1 58 approvable letters 58 oral ridaforolimus 58 Orphan Drug designation 58 Oracea 58 AGGRASTAT R 58 CAELYX 58 Vasovist 58 tiapamil 58 ofatumumab 58 palonosetron 58 ULTRASE 58 virus HCV protease inhibitor 58 Navelbine ® 58 Kepivance 58 Exforge HCT 58 Clevudine 58 CYCLOSET 58 GEM #S 58 thymalfasin 58 sitaxsentan sodium 58 cUTI 58 Sanvar R 58 zolmitriptan 58 olanzapine LAI 58 Mirapexin 57 Cethrin 57 Panzem R 57 gepirone ER 57 Vernakalant 57 REMINYL ® 57 TREDAPTIVE 57 REMOXY R 57 Cethromycin 57 Berinert 57 Alitretinoin 57 PhosLo 57 Phase IIb trials 57 ARIKACE 57 Exalgo 57 Valtropin 57 dextofisopam 57 FOSRENOL 57 efalizumab 57 BiovaxID TM 57 catheter occlusion 57 Specifid 57 Augment Injectable 57 paliperidone palmitate 57 lacosamide 57 phase IIb trial 57 Uplyso 57 IND Investigational New 57 NEUPOGEN 57 anticancer compound 57 FDA Orphan Drug 57 naproxcinod 57 GAMMAGARD 57 Phase III Clinical Trial 57 ZEGERID Powder 57 Troxatyl 57 ONCONASE 57 Neurodex 57 RSD# iv 57 targeted radiotherapeutic 57 tezampanel NGX# 57 GRAS notification 57 Rotarix R 57 Pegloticase 57 rFVIIa 57 Increlex TM 57 OMAPRO 57 Bayer Onyx 57 AZX# 57 Lodotra 57 Onalta ™ 57 dirucotide 57 granted Ortec 57 molecular imaging radiopharmaceutical 57 liver resection surgeries 57 FDA Complete Response 57 vaginal lidocaine 57 CytoFab 57 reslizumab 57 Febuxostat 57 Proxinium TM 57 Phase Ib study 57 EGS# 57 sitaxsentan 57 Chemophase 57 fidaxomicin 57 Amitiza 57 HFA MDI 57 R#/MEM 57 valopicitabine 57 IMGN# 57 #I TM# 57 tramiprosate Alzhemed TM 57 Biologics License Applications 57 OMNARIS HFA 57 Complete Response 57 RoACTEMRA 57 Bifeprunox 57 R sorafenib tablets 57 ARIKACE ™ 57 Japanese Encephalitis vaccine 57 Serdolect 57 aztreonam lysine 57 Phase #/#a 57 MONOVISC 57 anidulafungin 57 elacytarabine 57 Vilazodone 57 bovine thrombin 57 rhThrombin 57 REMOXY ® 57 Arixtra 57 Prosaptide 57 ularitide 57 Zemiva TM 57 satraplatin 57 HCV protease inhibitor 57 ganetespib 57 fluvoxamine maleate 57 LIVALO 57 BAL# [002] 57 Ecallantide 57 LUVENIQ 57 KRYSTEXXA TM pegloticase 57 Friedreich Ataxia FRDA 57 SURFAXIN 57 mesylate 57 NOXAFIL 57 POSIDUR 57 Topical Interferon Alpha 2b 57 IONSYS TM 57 Filgrastim 57 TAFA# 57 PROCHYMAL 57 DepoDur TM 57 SAR# [004] 57 Gynazole 1 57 daptomycin 57 ACZ# 57 LUMINATE 57 treat opioid induced 57 Ranexa R 57 Dexilant 57 candidate brentuximab vedotin 57 elagolix 57 anti arrhythmic 57 relapsed refractory multiple myeloma 57 Neupro 57 CELVAPAN H#N# 57 HCD# [002] 57 Vitaros 57 aclidinium 57 BEXXAR 57 posaconazole 57 AzaSite Plus 57 oral calcitonin 57 zileuton CR 57 Ketotransdel ® 57 Entereg alvimopan 57 subcutaneously administered 57 Cushing Syndrome 57 Mylotarg 57 Marqibo 57 Phase III clinical 57 XIAPEX 57 Kalbitor 57 CIP TRAMADOL ER 57 Cancidas 57 AMITIZA ® 57 BrachySil TM 57 Zactima 57 Ganite ® 57 Bezielle 57 Evoltra R 57 MOVIPREP R 57 NVA# 57 Urocidin TM 57 5 lipoxygenase inhibitor 57 Actemra 57 CANCIDAS 57 FROVA 57 midstage clinical 57 carfilzomib 57 Onsolis 57 clevudine 57 TheraCIM 57 Staphylococcus aureus Polysaccharide Conjugate 57 TYGACIL 57 Menerba 57 Advexin 57 Argatroban 57 Allovectin 7 r 57 torsemide ER 57 tezampanel 57 divalproex sodium 57 DepoDur 57 DR Cysteamine 57 supplemental Biologics License Application 57 Neovasc Reducer 57 www.soliris.net 57 Evamist TM 57 aripiprazole Abilify 57 ZADAXIN 57 RELISTOR 57 Pruvel 57 ENRICH trial 57 AOP Orphan 57 leading oral taxane 57 Anidulafungin 57 MAP# 57 Shigamabs R 57 LymphoStat B 57 oral taxane 57 postapproval 57 citalopram hydrobromide 57 hereditary deficiency 57 CoFactor 57 Arzerra ofatumumab 57 MAXY alpha 57 overactive bladder AA# 57 mertansine 57 ZEVALIN ® 57 TroVax ® 57 Vaprisol 57 Fibrin Pad 57 Pentacel vaccine 57 Dynepo 57 octagam ® 57 vernakalant oral 57 romiplostim 57 sulodexide 57 Cimzia certolizumab pegol 57 COLAZAL 57 INCB# [002] 57 cinacalcet HCl 57 PreHistin TM 57 Tasigna nilotinib 57 Proquin XR 57 Genasense ® 57 Vicinium TM 57 Abstral ® 57 Junovan 57 Onco TCS 57 Vectibix panitumumab 57 PGL# 57 SUPPRELIN R LA 57 PEG SN# 57 MethyPatch 57 frovatriptan 57 Onconase 57 lucinactant 57 ixabepilone 57 heterozygous FH 57 Sanctura XR 57 IMiDs 56 Egrifta 56 Dapagliflozin 56 Panzem 56 valdecoxib 56 tramiprosate ALZHEMED TM 56 perampanel 56 Cimzia 56 BYDUREON 56 Crofelemer 56 include Phenoptin TM 56 Known hypersensitivity 56 anti TNF alpha 56 Prodarsan 56 Ceftobiprole 56 vinorelbine emulsion 56 SEPET TM 56 BEMA Granisetron 56 BioNumerik 56 sNDA submission 56 proprietary transdermal patch 56 Lovaza TM 56 ELADUR ™ 56 PREOS 56 intranasal formulation 56 C1 inhibitor rhC1INH 56 Xifaxan rifaximin 56 vernakalant iv 56 voclosporin 56 SPIRIVA HandiHaler 56 KYNAPID 56 SinuNase ™ 56 TREANDA 56 novel trazodone formulation 56 Excellarate TM 56 Cloretazine ® 56 Nycomed GmbH 56 sublingual tablets 56 epratuzumab 56 Onrigin TM 56 Entereg TM 56 GATTEX TM 56 masitinib 56 faropenem medoxomil 56 PEG PAL 56 Phase III TRIST 56 Emend 56 Relistor 56 eritoran 56 Orencia abatacept 56 Octreolin 56 PS# [001] 56 phase IIb 56 Hycamtin 56 confirmatory Phase III 56 abatacept Orencia 56 Camvia 56 RECOTHROM R 56 novel oral anticoagulant 56 Zevtera 56 ELND# 56 Staccato loxapine 56 lorvotuzumab mertansine 56 dacetuzumab 56 XIAFLEX TM 56 Acetavance 56 afamelanotide 56 VISICOL R 56 eculizumab 56 Nuedexta 56 PDUFA Date 56 Pazopanib 56 Velcade bortezomib 56 Stelara 56 Thelin tm 56 fidaxomicin Phase 3 56 Certolizumab pegol 56 Photocure 56 Telzir 56 Betaferon ® 56 incyclinide 56 Veregen ® 56 candidate Zenvia 56 Phase 2a trial 56 DC Bead 56 Ganciclovir 56 JZP 56 thorough QT 56 zafirlukast 56 phase IIa 56 bardoxolone 56 Emselex 56 dimebon 56 Linjeta ™ 56 NanoCrystal technology 56 VIAject R 56 alogliptin 56 ISTODAX 56 brentuximab vedotin SGN 56 naproxen esomeprazole magnesium 56 Locteron ® 56 Velaglucerase Alfa 56 Androxal TM 56 EOquin TM 56 tolevamer 56 SEROQUEL XR 56 Ceflatonin 56 Excellagen 56 Azixa 56 clinical pharmacology studies 56 StaphVAX 56 ferumoxytol Injection 56 pivotal Phase III